Llovet JM - Search Results

1

A phase II trial of oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma.

Llovet JM, Ruff P, Tassopoulos N, Castells L, Bruix J, El-Hariry I, Peachey M. Llovet JM, et al. Eur J Cancer. 2001 Jul;37(11):1352-8. doi: 10.1016/s0959-8049(01)00100-9. Eur J Cancer. 2001. PMID: 11435064 Clinical Trial.

2

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.

Navasa M, Follo A, Llovet JM, Clemente G, Vargas V, Rimola A, Marco F, Guarner C, Forné M, Planas R, Bañares R, Castells L, Jimenez De Anta MT, Arroyo V, Rodés J. Navasa M, et al. Among authors: llovet jm. Gastroenterology. 1996 Oct;111(4):1011-7. doi: 10.1016/s0016-5085(96)70069-0. Gastroenterology. 1996. PMID: 8831596 Clinical Trial.

3

Pulmonary abscess as a complication of transarterial embolization of multinodular hepatocellular carcinoma.

Cubiella J, Sans M, Llovet JM, Bustamante J, Ferrer A, Caballeria J, Rodés J. Cubiella J, et al. Among authors: llovet jm. Am J Gastroenterol. 1997 Oct;92(10):1942-3. Am J Gastroenterol. 1997. PMID: 9382078

4

Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power.

Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, Franca A, Brú C, Navasa M, Ayuso MC, Solé M, Real MI, Vilana R, Rimola A, Visa J, Rodés J. Llovet JM, et al. Hepatology. 1998 Jun;27(6):1572-7. doi: 10.1002/hep.510270616. Hepatology. 1998. PMID: 9620329

5

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

Bruix J, Llovet JM, Castells A, Montañá X, Brú C, Ayuso MC, Vilana R, Rodés J. Bruix J, et al. Among authors: llovet jm. Hepatology. 1998 Jun;27(6):1578-83. doi: 10.1002/hep.510270617. Hepatology. 1998. PMID: 9620330 Clinical Trial.

6

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Brú C, Rodés J, Bruix J. Llovet JM, et al. Hepatology. 1999 Jan;29(1):62-7. doi: 10.1002/hep.510290145. Hepatology. 1999. PMID: 9862851 Clinical Trial.

7

Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Llovet JM, Brú C, Bruix J. Llovet JM, et al. Semin Liver Dis. 1999;19(3):329-38. doi: 10.1055/s-2007-1007122. Semin Liver Dis. 1999. PMID: 10518312

8

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Llovet JM, Fuster J, Bruix J. Llovet JM, et al. Hepatology. 1999 Dec;30(6):1434-40. doi: 10.1002/hep.510300629. Hepatology. 1999. PMID: 10573522

9

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma.

Llovet JM, Sala M, Castells L, Suarez Y, Vilana R, Bianchi L, Ayuso C, Vargas V, Rodés J, Bruix J. Llovet JM, et al. Hepatology. 2000 Jan;31(1):54-8. doi: 10.1002/hep.510310111. Hepatology. 2000. PMID: 10613728 Clinical Trial.

10

Locoregional treatments for hepatocellular carcinoma.

Bruix J, Llovet JM. Bruix J, et al. Among authors: llovet jm. Baillieres Best Pract Res Clin Gastroenterol. 1999 Dec;13(4):611-22. doi: 10.1053/bega.1999.0051. Baillieres Best Pract Res Clin Gastroenterol. 1999. PMID: 10654923 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters